{"nct_id":"NCT01282424","title":"Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2011-03-18","start_date_type":"ACTUAL","primary_completion_date":"2018-05-02","primary_completion_date_type":"ACTUAL","completion_date":"2018-05-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}